Dodo De‑Extinction in Motion: Colossal Biosciences’ Next Frontier
Ben Lamm, founder of Colossal Biosciences, is leading a bold mission to resurrect the extinct dodo via gene editing, avian breakthroughs, and rewilding plans.
Shirley Li, Staff Writer at The Atlantic, breaks down Paramount and WBD’s $111 billion merger and what it means for Hollywood, streaming and consumers.